ACAD - ACADIA PHARMACEUTICALS INC


23.39
0.890   3.805%

Share volume: 1,919,276
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$22.50
0.89
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-06-2024 11-06-2024 02-27-2025 05-08-2025 08-06-2025 11-05-2025 02-26-2026
Total revenue 205.831 M 241.963 M 250.401 M 259.602 M 244.317 M 264.566 M 278.633 M 283.989 M
Cost of revenue 22.951 M 18.230 M 18.857 M 21.803 M 20.392 M 20.734 M 21.647 M 26.225 M
Gross profit 182.880 M 223.733 M 231.544 M 237.799 M 223.925 M 243.832 M 256.986 M 257.764 M
    22.34% 3.49% 2.70% -5.83% 8.89% 5.39% 0.30%  
Operating expenses 167.670 M 193.296 M 199.900 M 230.811 M 204.635 M 211.458 M 221.230 M 240.373 M
Selling general and admin 107.991 M 117.063 M 133.294 M 130.080 M 126.370 M 133.507 M 133.401 M 155.616 M
Research and development 59.679 M 76.233 M 66.606 M 100.731 M 78.265 M 77.951 M 87.829 M 84.757 M
Total expenses 167.670 M 193.296 M 199.900 M 84.296 M 204.635 M 211.458 M 221.230 M 240.373 M
    15.28% 3.42% -57.83% 142.76% 3.33% 4.62% 8.65%  
Operating income 15.210 M 30.437 M 31.644 M 153.503 M 19.290 M 32.374 M 35.756 M 17.391 M
Ebit 15.496 M 30.823 M 32.220 M 153.503 M 19.878 M 32.968 M 36.349 M 17.987 M
Pretax income 21.002 M 37.182 M 38.806 M 161.085 M 27.779 M 40.211 M 44.595 M 26.319 M
    77.04% 4.37% 315.10% -82.76% 44.75% 10.90% -40.98%  
Income tax 4.447 M 3.793 M 6.041 M 17.343 M 8.792 M 13.545 M -27.184 M -247.249 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 16.555 M 33.389 M 32.765 M 143.742 M 18.987 M 26.666 M 71.779 M 273.568 M
    101.69% -1.87% 338.71% -86.79% 40.44% 169.18% 281.13%